ALHC vs. TMO: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ALHC and TMO, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
Symbol | ALHC | TMO |
---|---|---|
Company Name | Alignment Healthcare, Inc. | Thermo Fisher Scientific Inc. |
Country | United States | United States |
GICS Sector | Health Care | Health Care |
GICS Industry | Health Care Providers & Services | Life Sciences Tools & Services |
Market Capitalization | 3.50 billion USD | 202.47 billion USD |
Exchange | NasdaqGS | NYSE |
Listing Date | March 26, 2021 | March 17, 1980 |
Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ALHC and TMO by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
Symbol | ALHC | TMO |
---|---|---|
5-Day Price Return | 0.95% | 2.14% |
13-Week Price Return | 23.85% | 27.70% |
26-Week Price Return | -4.87% | 14.08% |
52-Week Price Return | 55.49% | -10.46% |
Month-to-Date Return | -2.69% | 10.55% |
Year-to-Date Return | 50.93% | 3.07% |
10-Day Avg. Volume | 3.29M | 3.15M |
3-Month Avg. Volume | 3.61M | 2.56M |
3-Month Volatility | 44.32% | 38.42% |
Beta | 1.21 | 0.89 |
Profitability
Return on Equity (TTM)
ALHC
-43.97%
Health Care Providers & Services Industry
- Max
- 24.86%
- Q3
- 15.79%
- Median
- 8.56%
- Q1
- 5.75%
- Min
- -1.64%
ALHC has a negative Return on Equity of -43.97%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
TMO
13.27%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
In the upper quartile for the Life Sciences Tools & Services industry, TMO’s Return on Equity of 13.27% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
ALHC
-1.53%
Health Care Providers & Services Industry
- Max
- 11.56%
- Q3
- 5.45%
- Median
- 2.83%
- Q1
- 1.13%
- Min
- -1.71%
ALHC has a negative Net Profit Margin of -1.53%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
TMO
15.23%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
TMO’s Net Profit Margin of 15.23% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ALHC
-0.83%
Health Care Providers & Services Industry
- Max
- 19.08%
- Q3
- 9.66%
- Median
- 4.77%
- Q1
- 2.46%
- Min
- -0.83%
ALHC has a negative Operating Profit Margin of -0.83%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
TMO
17.13%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
TMO’s Operating Profit Margin of 17.13% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
Symbol | ALHC | TMO |
---|---|---|
Return on Equity (TTM) | -43.97% | 13.27% |
Return on Assets (TTM) | -6.05% | 6.62% |
Net Profit Margin (TTM) | -1.53% | 15.23% |
Operating Profit Margin (TTM) | -0.83% | 17.13% |
Gross Profit Margin (TTM) | 12.14% | 41.34% |
Financial Strength
Current Ratio (MRQ)
ALHC
1.66
Health Care Providers & Services Industry
- Max
- 2.00
- Q3
- 1.51
- Median
- 1.29
- Q1
- 0.92
- Min
- 0.14
ALHC’s Current Ratio of 1.66 is in the upper quartile for the Health Care Providers & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
TMO
1.93
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
TMO’s Current Ratio of 1.93 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ALHC
2.29
Health Care Providers & Services Industry
- Max
- 2.29
- Q3
- 1.24
- Median
- 0.74
- Q1
- 0.50
- Min
- 0.00
ALHC’s leverage is in the upper quartile of the Health Care Providers & Services industry, with a Debt-to-Equity Ratio of 2.29. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
TMO
0.70
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
TMO’s Debt-to-Equity Ratio of 0.70 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
ALHC
-4.44
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.50
- Median
- 4.52
- Q1
- 2.12
- Min
- -4.44
ALHC has a negative Interest Coverage Ratio of -4.44. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
TMO
23.55
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
TMO’s Interest Coverage Ratio of 23.55 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
Symbol | ALHC | TMO |
---|---|---|
Current Ratio (MRQ) | 1.66 | 1.93 |
Quick Ratio (MRQ) | 1.49 | 1.50 |
Debt-to-Equity Ratio (MRQ) | 2.29 | 0.70 |
Interest Coverage Ratio (TTM) | -4.44 | 23.55 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ALHC
0.00%
Health Care Providers & Services Industry
- Max
- 5.93%
- Q3
- 2.59%
- Median
- 1.35%
- Q1
- 0.00%
- Min
- 0.00%
ALHC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
TMO
0.30%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Yield of 0.30% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
ALHC
0.00%
Health Care Providers & Services Industry
- Max
- 185.33%
- Q3
- 74.82%
- Median
- 36.00%
- Q1
- 0.00%
- Min
- 0.00%
ALHC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
TMO
9.27%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
TMO’s Dividend Payout Ratio of 9.27% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
Symbol | ALHC | TMO |
---|---|---|
Dividend Yield (TTM) | 0.00% | 0.30% |
Dividend Payout Ratio (TTM) | 0.00% | 9.27% |
Valuation
Price-to-Earnings Ratio (TTM)
ALHC
--
Health Care Providers & Services Industry
- Max
- 40.02
- Q3
- 29.75
- Median
- 21.09
- Q1
- 14.18
- Min
- 7.05
P/E Ratio data for ALHC is currently unavailable.
TMO
31.17
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
TMO’s P/E Ratio of 31.17 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ALHC
1.05
Health Care Providers & Services Industry
- Max
- 3.15
- Q3
- 1.87
- Median
- 0.74
- Q1
- 0.27
- Min
- 0.09
ALHC’s P/S Ratio of 1.05 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
TMO
4.75
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
TMO’s P/S Ratio of 4.75 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ALHC
19.65
Health Care Providers & Services Industry
- Max
- 7.33
- Q3
- 4.45
- Median
- 2.52
- Q1
- 1.15
- Min
- 0.66
At 19.65, ALHC’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
TMO
3.03
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
TMO’s P/B Ratio of 3.03 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
Symbol | ALHC | TMO |
---|---|---|
Price-to-Earnings Ratio (TTM) | -- | 31.17 |
Price-to-Sales Ratio (TTM) | 1.05 | 4.75 |
Price-to-Book Ratio (MRQ) | 19.65 | 3.03 |
Price-to-Free Cash Flow Ratio (TTM) | 75.50 | 33.26 |